SLMC.DE vs. 2B70.DE
Compare and contrast key facts about iShares MSCI Europe ESG Screened UCITS ETF EUR (Acc) (SLMC.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE).
SLMC.DE and 2B70.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. SLMC.DE is a passively managed fund by iShares that tracks the performance of the MSCI Europe ESG Screened. It was launched on Oct 19, 2018. 2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017. Both SLMC.DE and 2B70.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SLMC.DE or 2B70.DE.
Key characteristics
| SLMC.DE | 2B70.DE | |
|---|---|---|
| YTD Return | 8.65% | 14.75% |
| 1Y Return | 16.99% | 31.27% |
| 3Y Return (Ann) | 4.70% | 2.58% |
| 5Y Return (Ann) | 7.32% | 8.13% |
| Sharpe Ratio | 1.52 | 1.87 |
| Sortino Ratio | 2.12 | 2.76 |
| Omega Ratio | 1.27 | 1.33 |
| Calmar Ratio | 2.16 | 1.23 |
| Martin Ratio | 9.03 | 8.57 |
| Ulcer Index | 1.76% | 3.59% |
| Daily Std Dev | 10.54% | 16.66% |
| Max Drawdown | -34.92% | -30.87% |
| Current Drawdown | -4.00% | -0.23% |
Correlation
The correlation between SLMC.DE and 2B70.DE is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SLMC.DE vs. 2B70.DE - Performance Comparison
In the year-to-date period, SLMC.DE achieves a 8.65% return, which is significantly lower than 2B70.DE's 14.75% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SLMC.DE vs. 2B70.DE - Expense Ratio Comparison
SLMC.DE has a 0.12% expense ratio, which is lower than 2B70.DE's 0.35% expense ratio.
Risk-Adjusted Performance
SLMC.DE vs. 2B70.DE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares MSCI Europe ESG Screened UCITS ETF EUR (Acc) (SLMC.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SLMC.DE vs. 2B70.DE - Dividend Comparison
Neither SLMC.DE nor 2B70.DE has paid dividends to shareholders.
Drawdowns
SLMC.DE vs. 2B70.DE - Drawdown Comparison
The maximum SLMC.DE drawdown since its inception was -34.92%, which is greater than 2B70.DE's maximum drawdown of -30.87%. Use the drawdown chart below to compare losses from any high point for SLMC.DE and 2B70.DE. For additional features, visit the drawdowns tool.
Volatility
SLMC.DE vs. 2B70.DE - Volatility Comparison
iShares MSCI Europe ESG Screened UCITS ETF EUR (Acc) (SLMC.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) have volatilities of 4.07% and 3.90%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.